All News

Artificial intelligence shows promise in improving diagnosis and treatment for patients with multiple myeloma.

Early diagnosis of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) may mitigate progression.

Automation and artificial intelligence can also aid significantly in reducing time-consuming tasks and improving efficiency for pharmacists, allowing them more time with patients.

The authors note that changes in the adolescent guidelines for meningococcal and human papillomavirus vaccines may cause inconsistencies and nonadherence.

Long-term shedding of mutated variants could pose a concern for spread among the public.

Treatment is typically tailored to the individuals, with HCT being the only curative treatment bone marrow failure, but long-term outcomes are generally poorer due to toxicities.

Although Madabhushi said there are emerging tools for clinical decision support, he said there is a greater need for tools further downstream in the post-diagnosis stages.

However, early diagnosis still presents challenges and limits treatment options.

Additional education can address ambivalence for patients and providers, which can start at the pharmacist level, as they are essential sources of information for patients.

About 72% of the observed pregnancies after allogeneic hematopoietic cell transplantation occurred spontaneously, whereas remaining pregnancies were a result of assisted reproductive activities.

Although psychotherapy is the cornerstone, nutritional education and pharmacotherapies can also help patients recover

Influenza, COVID-19, and RSV vaccines are a critical part of MTM services

As the end of the DSCSA stabilization period approaches, Josh Bolin from the NABP provides an overview of what to expect.

Researchers found that PF4/Cxcl4, a key driver of fibrosis, was up regulated on all proteomes.

Investigators reported that more than half of individuals had great knowledge about protecting themselves from COVID-19.

Compared with chemotherapy, datopotamab deruxtecan (Dato-DXd) did not achieve a statistically significant overall survival (OS) in patients with inoperable or metastatic HR+/HER2-low or negative breast cancer.

The FDA assigned a Prescription Drug User Fee Act action date of May 22, 2025.

The meeting will focus on the basic, preclinical, and clinical aspects of myeloma, including precursor disease, high-risk disease, immunotherapies, novel biomarkers, and more.

Each stage of the CGM battery lifecycle contains the potential for detrimental environmental impact.

Pharmacy students discuss a non-traditional learning assignment that used the social media platform, TikTok.

As technicians are increasingly involved in decision-making, they must exude confidence and advocate for themselves

William Carroll, PharmD, network vice president of pharmacy at Hackensack Meridian Health, discusses his hopes for the new partnership.

Childhood immunization according to schedule can prevent serious illness.

Further trials are required to examine the long-term feasibility of intravenous immunoglobulin (IVIG) for multisystem inflammatory syndrome.

Erin McConnell, PharmD, discuss the clinical decision-making process for choosing between statins, PSCK9 inhibitors, or newer agents like inclisiran.

Erin McConnell, PharmD, discusses the importance of effective cholesterol management for preventing heart disease.

A 95% increase in private health center participation, monitoring, assessment, and vaccine coverage can be significant in improving outcomes.

Although dry-powder and soft-mist inhalers had significantly lower emissions, they represented nearly two-thirds of inhaler costs but one-third of claims.

If approved, delgocitinib cream would be the first US treatment indicated for moderate to severe chronic hand eczema.